Based on the TIP30 expression results in tumour cells, 105 patients were divided into a high-expressing (n=59) and low-expressing group (n=46), and the correlations between TIP30 expression and clinicopathologic features were analysed. This evidence concerns the gene HTATIP2 and neoplasm.